Teva-triamterene/hctz (2020-07-24)

Teva-Triamterene/HCTZ Recall Teva is recalling Triamterene/HCTZ, a medication used to treat high blood pressure, across Canada due to a product safety issue. The recall is classified as Class I, meaning there is a serious potential health risk. This recall affects all Canadian consumers who have this medication.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-07-24

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/81c7488a-e991-4c9d-a2fd-0ff0f5680e72